We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Dynavax DVAX
An SI Board Since August 2004
Posts SubjectMarks Bans Symbol
187 24 0 DVAX
Emcee:  keokalani'nui Type:  Moderated
IPO 2/20/04 at $7.50

Clinical Programs:

--Ragweed/Seasonal Allergy
--Hep B

8/04 price: $5.00
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
187But TLR9 + Nivolumab (anti-PD-1) whiffs in NSCLC, per data at AACR. Perceived atuck-4/2/2019
186Earnings out yesterday. I think that DVAX has found its footing. A few tidbitsLabrador12/27/2019
185I take it that some have figured out that DVAX is going to badly miss its 2019 rLabrador-2/7/2019
184$3.7 million for the quarter. That's the beginning of the inflection point?scaram(o)uche-1/11/2019
183"clear route to approval"............ the man is INSANE. Spends hscaram(o)uche-1/10/2019
182:-) I consider this to be a message LIST.scaram(o)uche-12/19/2018
181But you're the one posting on it.... :-) Ducks.nigel bates-12/19/2018
180Dysfunctional Board. Lazy Board. Incompetent Board.scaram(o)uche-12/18/2018
179Death from a thousand cuts, while we're waiting for these clowns to deliver.scaram(o)uche-11/29/2018
178September a record month!! (Sales of $1.5M for the quarter, Dude...... ya puscaram(o)uche-11/6/2018
177The Board is simply useless. Get Carson, Kisner and Gray in one room, and expecscaram(o)uche-11/5/2018
176DVAX is in action. On watch for clear above 13.75. [graphic]Alejandroo Green-10/24/2018
175Vk? @biotechinvstr21h21 hours ago More If there's anything that's the scaram(o)uche-10/23/2018
174Single arm, drag it out as long as possible, talk about phase III and a partner.scaram(o)uche-10/22/2018
173Seems like the continuing theme of I/O: takes longer to work. And the encouragituck-10/22/2018
172Andy Biotech? @AndyBiotech5m5 minutes ago Andy Biotech Retweeted NYCDoc29 $MRKscaram(o)uche-10/22/2018
171Just dumber than dirt. Goes on and on and on.scaram(o)uche-10/21/2018
170>> The median progression-free survival was 2.0 months (95% CI, 1.9 to 2.1scaram(o)uche-10/20/2018
169Just came across this: HNSCC SD-101 TLR9 with Pembro in PD-1 naive pts Duratiotuck-10/20/2018
168Link to webcast is live, but all you get is music. Why have a live link? I meascaram(o)uche110/20/2018
167I just don't see a sense of urgency from this crew.scaram(o)uche-9/26/2018
166There will also be updates for anti-PD-1 "progressors" (all at 8 mg, nscaram(o)uche-9/26/2018
165ESMO late breaker (melanoma, PD-1 naive) title out, and it's as generic as cscaram(o)uche-9/26/2018
164Not holding my breath. However, always looking for something below radar...... scaram(o)uche-9/24/2018
163missed these...... ncbi.nlm.nih.govscaram(o)uche-9/24/2018
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):